Pancreatic cancer

Safa Aiad Al-Bazy; Mikkel Parsberg Werge; Lise Lotte Gluud; Christina Therkildsen; Srdan Novovic

Pancreatic cancer

Translated title of the contribution: Not Available

Abstract

Pancreatic cancer poses a challenge in healthcare and is one of a leading cause of cancer-related mortality. In 2021, around 1,000 new cases were diagnosed in Denmark. The disease itself is associated with a poor prognosis. Partly due to its silent nature and partly due to the lack of sensitive and specific tumour markers for early detection. The five-year survival rate among patients with pancreatic cancer in Denmark is 5-6%. I this review, we describe the current diagnostic and treatment options as well as the status on cancer-predictive biomarkers and their screening potential.

Translated title of the contribution	Not Available
Original language	Danish
Journal	Ugeskrift for Laeger
Volume	185
Issue number	23
ISSN	0041-5782
Publication status	Published - 5 Jun 2023

Cite this

@article{522ad00ad8c34264a69e2f951426c213,

title = "Pancreatic cancer",

abstract = "Pancreatic cancer poses a challenge in healthcare and is one of a leading cause of cancer-related mortality. In 2021, around 1,000 new cases were diagnosed in Denmark. The disease itself is associated with a poor prognosis. Partly due to its silent nature and partly due to the lack of sensitive and specific tumour markers for early detection. The five-year survival rate among patients with pancreatic cancer in Denmark is 5-6\%. I this review, we describe the current diagnostic and treatment options as well as the status on cancer-predictive biomarkers and their screening potential.",

keywords = "Humans, Early Detection of Cancer, Pancreatic Neoplasms/diagnosis, Biomarkers, Tumor, Prognosis",

author = "Al-Bazy, \{Safa Aiad\} and Werge, \{Mikkel Parsberg\} and Gluud, \{Lise Lotte\} and Christina Therkildsen and Srdan Novovic",

year = "2023",

month = jun,

day = "5",

language = "Dansk",

volume = "185",

journal = "Ugeskrift for Laeger",

issn = "0041-5782",

publisher = "Almindelige Danske L{\ae}geforening",

number = "23",

}

TY - JOUR

T1 - Pancreatic cancer

AU - Al-Bazy, Safa Aiad

AU - Werge, Mikkel Parsberg

AU - Gluud, Lise Lotte

AU - Therkildsen, Christina

AU - Novovic, Srdan

PY - 2023/6/5

Y1 - 2023/6/5

N2 - Pancreatic cancer poses a challenge in healthcare and is one of a leading cause of cancer-related mortality. In 2021, around 1,000 new cases were diagnosed in Denmark. The disease itself is associated with a poor prognosis. Partly due to its silent nature and partly due to the lack of sensitive and specific tumour markers for early detection. The five-year survival rate among patients with pancreatic cancer in Denmark is 5-6%. I this review, we describe the current diagnostic and treatment options as well as the status on cancer-predictive biomarkers and their screening potential.

AB - Pancreatic cancer poses a challenge in healthcare and is one of a leading cause of cancer-related mortality. In 2021, around 1,000 new cases were diagnosed in Denmark. The disease itself is associated with a poor prognosis. Partly due to its silent nature and partly due to the lack of sensitive and specific tumour markers for early detection. The five-year survival rate among patients with pancreatic cancer in Denmark is 5-6%. I this review, we describe the current diagnostic and treatment options as well as the status on cancer-predictive biomarkers and their screening potential.

KW - Humans

KW - Early Detection of Cancer

KW - Pancreatic Neoplasms/diagnosis

KW - Biomarkers, Tumor

KW - Prognosis

UR - https://www.scopus.com/pages/publications/85163267705

M3 - Review

C2 - 37325980

SN - 0041-5782

VL - 185

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

IS - 23

ER -

Pancreatic cancer

Abstract

Other files and links

Fingerprint

Cite this